BR8104189A - Polipeptideos,sequencias de dna,veiculo de expressao,plasmideo,microorganismo,bacteria,linhagem de e.coli,composicao contendo polipeptideo,extrato,composicao farmaceutica,cultura de celulas microbiais,usos de alguns desses itens,e processos de preparacao - Google Patents

Polipeptideos,sequencias de dna,veiculo de expressao,plasmideo,microorganismo,bacteria,linhagem de e.coli,composicao contendo polipeptideo,extrato,composicao farmaceutica,cultura de celulas microbiais,usos de alguns desses itens,e processos de preparacao

Info

Publication number
BR8104189A
BR8104189A BR8104189A BR8104189A BR8104189A BR 8104189 A BR8104189 A BR 8104189A BR 8104189 A BR8104189 A BR 8104189A BR 8104189 A BR8104189 A BR 8104189A BR 8104189 A BR8104189 A BR 8104189A
Authority
BR
Brazil
Prior art keywords
polypeptideos
polypeeptide
plasmide
lineage
microorganism
Prior art date
Application number
BR8104189A
Other languages
English (en)
Portuguese (pt)
Inventor
David N Goeddel
S Pestka
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27496622&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR8104189(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/256,204 external-priority patent/US6610830B1/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR8104189A publication Critical patent/BR8104189A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BR8104189A 1980-07-01 1981-07-01 Polipeptideos,sequencias de dna,veiculo de expressao,plasmideo,microorganismo,bacteria,linhagem de e.coli,composicao contendo polipeptideo,extrato,composicao farmaceutica,cultura de celulas microbiais,usos de alguns desses itens,e processos de preparacao BR8104189A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16498680A 1980-07-01 1980-07-01
US18490980A 1980-09-08 1980-09-08
US20557880A 1980-11-10 1980-11-10
US06/256,204 US6610830B1 (en) 1980-07-01 1981-04-21 Microbial production of mature human leukocyte interferons

Publications (1)

Publication Number Publication Date
BR8104189A true BR8104189A (pt) 1982-03-16

Family

ID=27496622

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8104189A BR8104189A (pt) 1980-07-01 1981-07-01 Polipeptideos,sequencias de dna,veiculo de expressao,plasmideo,microorganismo,bacteria,linhagem de e.coli,composicao contendo polipeptideo,extrato,composicao farmaceutica,cultura de celulas microbiais,usos de alguns desses itens,e processos de preparacao

Country Status (36)

Country Link
EP (2) EP0211148B2 (enExample)
AR (1) AR242833A1 (enExample)
AT (3) AT380272B (enExample)
AU (1) AU552004B2 (enExample)
BG (1) BG42189A3 (enExample)
BR (1) BR8104189A (enExample)
CH (2) CH651308A5 (enExample)
CS (1) CS273152B2 (enExample)
DD (3) DD202307A5 (enExample)
DE (3) DE3176448D1 (enExample)
DK (1) DK173543B1 (enExample)
DZ (1) DZ312A1 (enExample)
ES (1) ES503528A0 (enExample)
FI (1) FI82712C (enExample)
FR (1) FR2486098B1 (enExample)
GB (1) GB2079291B (enExample)
GE (1) GEP19960519B (enExample)
GR (1) GR75714B (enExample)
HK (1) HK49285A (enExample)
HU (1) HU196457B (enExample)
IE (1) IE49255B1 (enExample)
IT (1) IT1137272B (enExample)
KE (1) KE3534A (enExample)
LU (1) LU83461A1 (enExample)
MC (1) MC1396A1 (enExample)
MY (1) MY8700711A (enExample)
NL (1) NL8103151A (enExample)
NO (1) NO159392C (enExample)
NZ (1) NZ197572A (enExample)
PH (1) PH18036A (enExample)
PL (3) PL148276B1 (enExample)
PT (1) PT73289B (enExample)
RO (1) RO87590A (enExample)
SE (2) SE465223C5 (enExample)
SU (1) SU1414319A3 (enExample)
YU (1) YU47700B (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
GR74498B (enExample) 1980-04-03 1984-06-28 Biogen Inc
ATE25985T1 (de) * 1980-06-12 1987-04-15 Japan Found Cancer Plasmid.
DK489481A (da) * 1980-11-10 1982-05-11 Searle & Co Plasmidvektor og frmgangsmaade til fremstilling deraf
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
EP0085693A1 (en) * 1981-08-14 1983-08-17 A/S Alfred Benzon Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
US4973479A (en) * 1982-01-15 1990-11-27 Cetus Corporation Interferon-α61
US4975276A (en) * 1982-01-15 1990-12-04 Cetus Corporation Interferon-alpha 54
US5098703A (en) * 1982-01-15 1992-03-24 Cetus Corporation Interferon-alpha 76
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
EP0088994B1 (en) * 1982-03-15 1991-06-19 Schering Corporation Hybrid dna, binding composition prepared thereby and processes therefor
US4695543A (en) * 1982-03-23 1987-09-22 Bristol-Myers Company Alpha Interferon GX-1
US4748233A (en) * 1982-03-23 1988-05-31 Bristol-Myers Company Alpha-interferon Gx-1
CA1210714A (en) * 1982-03-23 1986-09-02 Alan Sloma .alpha.-INTERFERON GX-1
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4751287A (en) * 1983-02-24 1988-06-14 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr Human leukocyte interferon N and a method of producing same in bacterial cells
EP0165942A1 (en) * 1983-12-23 1986-01-02 Monash University PRODUCTION OF HUMAN INTERFERON-$g(a)
SU1364343A1 (ru) * 1984-07-13 1988-01-07 Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Способ получени человеческого лейкоцитарного интерферона альфа-2
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
WO1986002068A1 (fr) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Separation mutuelle de proteines
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
JP2514950B2 (ja) * 1986-03-10 1996-07-10 エフ・ホフマン―ラ ロシユ アーゲー 化学修飾蛋白質，その製造法および中間体
JPS6463395A (en) * 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
CA1309044C (en) * 1987-11-09 1992-10-20 Toshiya Takano Method of producing foreign gene products
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
WO1991003251A1 (en) * 1989-09-08 1991-03-21 California Institute Of Biological Research Cr2 ligand compositions and methods for modulating immune cell functions
DE3932311A1 (de) * 1989-09-28 1991-04-11 Boehringer Ingelheim Int Verfahren zur reinigung von beta-interferon
US6007805A (en) * 1994-03-07 1999-12-28 Imperial College Of Science And Technology Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver
EP1104809A1 (en) * 1994-04-09 2001-06-06 F. Hoffmann-La Roche Ag Process for producing alpha-interferon
GB9609932D0 (en) * 1996-05-13 1996-07-17 Hoffmann La Roche Use of IL-12 and IFN alpha for the treatment of infectious diseases
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
AU761577C (en) 1997-12-08 2004-02-05 Genentech Inc. Human interferon-epsilon: a type I interferon
ZA9811070B (en) 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
PT1588716E (pt) 1998-08-06 2011-05-25 Mountain View Pharmaceuticals Conjugados de peg-urato oxidase e sua utiliza??o
US6268178B1 (en) 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
EP1355939A2 (en) * 2000-11-03 2003-10-29 Pestka Biomedical Laboratories, Inc. Interferons, uses and compositions related thereto
FR2822845B1 (fr) 2001-03-30 2003-12-12 Genodyssee Nouveaux polynucleotides comportant des polymorphismes de type snp fonctionnels dans la sequence nucleotidique du gene ifn-alpha-21 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
LT3321359T (lt) 2005-04-11 2021-05-10 Horizon Pharma Rheumatology Llc Urato oksidazės variantinės formos ir jų panaudojimas
WO2009090056A2 (en) * 2008-01-18 2009-07-23 F. Hoffmann-La Roche Ag Purification of not-glycosylated polypeptides
PL398781A1 (pl) 2009-06-25 2012-11-19 Savient Pharmaceuticals, Inc. Sposoby i zestawy do prognozowania ryzyka wystapienia reakcji na wlew oraz zaniku odpowiedzi której posrednicza przeciwciala poprzez monitorowanie kwasu moczowego w surowicy podczas terapii z zastosowaniem pegylowanej urykazy
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
WO2018087345A1 (en) 2016-11-14 2018-05-17 F. Hoffmann-La Roche Ag COMBINATION THERAPY OF AN HBsAg INHIBITOR, A NUCLEOS(T)IDE ANALOGUE AND AN INTERFERON
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150740B (enExample) * 1978-11-24 1982-12-04 Hoffmann La Roche
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
EP0032134B2 (en) * 1980-01-08 1993-10-13 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human interferon-alpha like polypeptides
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
ATE25985T1 (de) * 1980-06-12 1987-04-15 Japan Found Cancer Plasmid.
ES506955A0 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
DE3280127D1 (de) * 1981-03-27 1990-04-12 Ici Plc Genetisch modifizierte mikroorganismen.

Also Published As

Publication number Publication date
FI82712C (fi) 1991-04-10
GR75714B (enExample) 1984-08-02
NO812247L (no) 1982-01-04
AR242833A1 (es) 1993-05-31
EP0211148B1 (en) 1992-08-26
EP0211148B2 (en) 1999-11-24
CH651308A5 (de) 1985-09-13
CS503781A2 (en) 1990-07-12
EP0043980B1 (en) 1987-09-16
EP0043980A2 (en) 1982-01-20
PL231940A1 (en) 1983-07-18
AT380272B (de) 1986-05-12
KE3534A (en) 1985-06-07
EP0043980A3 (en) 1982-09-15
MC1396A1 (fr) 1982-04-27
DE3125706A1 (de) 1982-04-15
DD202307A5 (de) 1983-09-07
SE465223B (sv) 1991-08-12
CS273152B2 (en) 1991-03-12
IE49255B1 (en) 1985-09-04
EP0211148A1 (en) 1987-02-25
GEP19960519B (en) 1996-07-02
DE3177288T2 (de) 1992-12-10
DK173543B1 (da) 2001-02-05
DD210305A5 (de) 1984-06-06
SE465223C5 (sv) 1998-02-10
NL8103151A (nl) 1982-02-01
ATE29727T1 (de) 1987-10-15
GB2079291B (en) 1984-06-13
FI812067L (fi) 1982-01-02
PT73289B (en) 1983-05-11
ATE79901T1 (de) 1992-09-15
LU83461A1 (de) 1983-04-06
IE811463L (en) 1982-01-01
DE3177288D1 (de) 1992-10-01
FR2486098A1 (fr) 1982-01-08
YU47700B (sh) 1996-01-08
FI82712B (fi) 1990-12-31
ATA290981A (de) 1985-09-15
PL148260B1 (en) 1989-09-30
ES8207514A1 (es) 1982-10-01
DE3177288T3 (de) 2000-03-16
RO87590A (ro) 1986-07-30
NO159392B (no) 1988-09-12
YU162281A (en) 1984-02-29
AU7246281A (en) 1982-01-07
PL148261B1 (en) 1989-09-30
HK49285A (en) 1985-07-05
NZ197572A (en) 1985-07-31
SE8104093L (sv) 1982-01-02
DD210304A5 (de) 1984-06-06
ES503528A0 (es) 1982-10-01
HU196457B (en) 1988-11-28
DK291081A (da) 1982-01-02
IT8122682A0 (it) 1981-07-01
PL148276B1 (en) 1989-09-30
PT73289A (en) 1981-07-01
FR2486098B1 (fr) 1985-12-27
NO159392C (no) 1988-12-21
GB2079291A (en) 1982-01-20
SU1414319A3 (ru) 1988-07-30
CH657141A5 (de) 1986-08-15
AU552004B2 (en) 1986-05-22
BG42189A3 (en) 1987-10-15
IT1137272B (it) 1986-09-03
MY8700711A (en) 1987-12-31
DE3125706C2 (de) 1995-05-24
DZ312A1 (fr) 2004-09-13
PH18036A (en) 1985-03-06
DE3176448D1 (en) 1987-10-22

Similar Documents

Publication Publication Date Title
BR8104189A (pt) Polipeptideos,sequencias de dna,veiculo de expressao,plasmideo,microorganismo,bacteria,linhagem de e.coli,composicao contendo polipeptideo,extrato,composicao farmaceutica,cultura de celulas microbiais,usos de alguns desses itens,e processos de preparacao
BR8106137A (pt) Polipeptidio sequencia de dna veiculo de expressao microbiiana copiavel plasmidio microorganismo composicao extrato bacteriano composicao farmaceutica cultura de celulas microbianas aplicacao de um interferon e processos de producaode alguns desses itens
IT8820920A0 (it) Dispositivo di fermentazione per la coltura aerobica di microorganismi.
BR8700045A (pt) Nitrilase bacteriana,hospedeiro bacteriano,composicao bacteria hospedeira,cassete de expressao,plasmidio,sequencia de dna,celula de planta e planta
DE3888642D1 (de) Rollflasche zur Züchtung von Zellengewebekulturen.
NO884422D0 (no) Stabil amplifikasjon av gener i kromosalt dna til prokaryote mikroorganismer.
EP0400958A3 (en) Live vaccines
AU9058091A (en) Preparation of nucleic acid samples
AU7947591A (en) Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages
DE3669327D1 (de) Fluessiges lebensfaehige mikroorganismen enthaltendes reinigungsmittel.
EP0281547A3 (en) Apparatus for the culture of microorganisms in the dormant state, particularly filamentous microorganisms
FI821962A7 (fi) Mantelihappo-johdannaiset ja mandelonitriilit, menetelmät niiden valmistamiseksi ja niiden käyttö mmikro-organismien torjumiseksi.
BR8205954A (pt) Sequencia de dna,plasmidio recombinante,cultura bacteriana e microorganismos
EP0072864A4 (en) FABRIC CULTURE MEDIUM.
Nanninga et al. Cell growth, genome duplication, and cell division.
ATE1249T1 (de) Gereinigte bakterielle proteoglycane, verfahren zu ihrer herstellung und sie enthaltender impfstoff.
Laird et al. Plasmid-associated toxigenicity in Clostridium tetani
IL75963A0 (en) Interferon derivatives,their preparation and pharmaceutical compositions containing them
ES8402346A1 (es) Procedimiento para la obtencion de lineas de celulas animales y humanas cultivables permanentemente.
IE39846B1 (en) Disinfection and sterilisation of mussels croustacea and fish
ES2089219T3 (es) Secuencias nucleicas del genoma de salmonella typhi y usos de las mismas, especialmente para el diagnostico in vitro de la presencia de bacterias del genero salmonella en los productos alimenticios.
IT1216140B (it) Procedimento per preparare alghe aventi effetti biologici migliorati.
AR225362A1 (es) Composicion esporicida desinfectante y esterilizante,excluidos sus usos farmaceuticos
AU3696189A (en) Improved composition for isolating and purifying nucleic acid and improved method using same
DE3266358D1 (en) Cell culture method